Literature DB >> 20508155

Dominant role of the MyD88-dependent signaling pathway in mediating early endotoxin-induced murine ileus.

Bettina M Buchholz1, Timothy R Billiar, Anthony J Bauer.   

Abstract

TLR4 ligation by pathogen-associated molecular patterns, such as Gram-negative bacteria-derived LPS, triggers a nonhematopoietic cell-mediated ileus during early endotoxemia. Our objective was to investigate the quantitative contributions of the two downstream signaling pathways of TLR4, namely the adapter proteins myeloid differentiation primary response gene 88 (MyD88) and Toll-IL-1-resistance (TIR) domain-containing adaptor-inducing IFN-beta (TRIF). Six hours after intraperitoneal injection of highly purified LPS (UP-LPS, 5 mg/kg), in vivo gastrointestinal transit and intestinal muscularis gene transcripts of inflammatory mediators chemokine (C-X-C motif) ligand 10, synonymous IP-10 (CXCL10), granulomonocyte colony stimulating factor (GM-CSF, synonymous CSF-2), IL-1beta, IL-6, IL-10, and inducible NO synthase (iNOS) were assessed in mice with transgenic loss-of-function for MyD88 or TRIF. LPS-induced MyD88 and TRIF mRNA upregulation was quantified within the intestinal muscularis of TLR4-competent and TLR4-mutant mice, and MyD88 mRNA levels were additionally measured in TLR4 bone marrow chimeras. MyD88 deficiency completely protected mice from early endotoxin-induced ileus, while TRIF deficiency partially ameliorated ileus severity. LPS induction of the primary downstream signaling element MyD88 was TLR4 dependent and was derived in equal amounts from both the hematopoietic and the nonhematopoietic cells. Conversely, no induction of TRIF mRNA was detectable. Significant gene induction of all inflammatory mediators was dependent on intracellular signal transduction by MyD88, while the TRIF MyD88-independent pathway predominantly regulated the molecular levels of CXCL10. In summary, MyD88 and TRIF are nonredundant signaling pathways in early endotoxin-induced rodent ileus, but MyD88 is the essential adaptor molecule for transduction of early TLR4-induced ileus and inflammatory signaling. The dependency of ileus on individual adaptor protein pathways is also reflected in the manifestation of specific molecular inflammatory events within the intestinal muscularis externa.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20508155      PMCID: PMC2928536          DOI: 10.1152/ajpgi.00060.2010

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  36 in total

1.  Eradication of the commensal intestinal microflora by oral antimicrobials interferes with the host response to lipopolysaccharide.

Authors:  T Umenai; H Hirai; N Shime; T Nakaya; T Asahara; K Nomoto; M Kita; Y Tanaka; J Imanishi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-03-20       Impact factor: 3.267

2.  Release of IL-12 by dendritic cells activated by TLR ligation is dependent on MyD88 signaling, whereas TRIF signaling is indispensable for TLR synergy.

Authors:  Mathias Krummen; Sandra Balkow; Limei Shen; Stefanie Heinz; Carmen Loquai; Hans-Christian Probst; Stephan Grabbe
Journal:  J Leukoc Biol       Date:  2010-04-01       Impact factor: 4.962

3.  TLR4/MyD88/PI3K interactions regulate TLR4 signaling.

Authors:  Michelle H W Laird; Sang Hoon Rhee; Darren J Perkins; Andrei E Medvedev; Wenji Piao; Matthew J Fenton; Stefanie N Vogel
Journal:  J Leukoc Biol       Date:  2009-03-16       Impact factor: 4.962

4.  Toll-like receptors 3, 4, and 7 are expressed in the enteric nervous system and dorsal root ganglia.

Authors:  Isabella Barajon; Graziano Serrao; Francesca Arnaboldi; Emanuela Opizzi; Gerlomina Ripamonti; Andrea Balsari; Cristiano Rumio
Journal:  J Histochem Cytochem       Date:  2009-06-22       Impact factor: 2.479

5.  Lipopolysaccharide stimulates the MyD88-independent pathway and results in activation of IFN-regulatory factor 3 and the expression of a subset of lipopolysaccharide-inducible genes.

Authors:  T Kawai; O Takeuchi; T Fujita; J Inoue; P F Mühlradt; S Sato; K Hoshino; S Akira
Journal:  J Immunol       Date:  2001-11-15       Impact factor: 5.422

Review 6.  Ileus in critical illness: mechanisms and management.

Authors:  Anthony J Bauer; Nicolas T Schwarz; Beverley A Moore; Andreas Türler; Jörg C Kalff
Journal:  Curr Opin Crit Care       Date:  2002-04       Impact factor: 3.687

7.  TRIF signaling stimulates translation of TNF-alpha mRNA via prolonged activation of MK2.

Authors:  Petra Gais; Christopher Tiedje; Felicitas Altmayr; Matthias Gaestel; Heike Weighardt; Bernhard Holzmann
Journal:  J Immunol       Date:  2010-04-07       Impact factor: 5.422

8.  Identification of Lps2 as a key transducer of MyD88-independent TIR signalling.

Authors:  K Hoebe; X Du; P Georgel; E Janssen; K Tabeta; S O Kim; J Goode; P Lin; N Mann; S Mudd; K Crozat; S Sovath; J Han; B Beutler
Journal:  Nature       Date:  2003-07-20       Impact factor: 49.962

9.  Cellular factors involved in CXCL8 expression induced by glycated serum albumin in vascular smooth muscle cells.

Authors:  Kyung-Ha Choi; Jae-woo Park; Hye-Young Kim; Young-Hee Kim; Sun-Mi Kim; Yong-Hae Son; Young-Chul Park; Seong-Kug Eo; Koanhoi Kim
Journal:  Atherosclerosis       Date:  2009-08-21       Impact factor: 5.162

10.  Cutting edge: myeloid differentiation factor 88 deficiency improves resistance against sepsis caused by polymicrobial infection.

Authors:  Heike Weighardt; Simone Kaiser-Moore; Ramunas M Vabulas; Carsten J Kirschning; Hermann Wagner; Bernhard Holzmann
Journal:  J Immunol       Date:  2002-09-15       Impact factor: 5.422

View more
  11 in total

1.  Endotoxin-induced uveitis is primarily dependent on radiation-resistant cells and on MyD88 but not TRIF.

Authors:  J Kezic; S Taylor; S Gupta; S R Planck; H L Rosenzweig; J T Rosenbaum
Journal:  J Leukoc Biol       Date:  2011-05-24       Impact factor: 4.962

2.  Cathepsin L promotes Vascular Intimal Hyperplasia after Arterial Injury.

Authors:  Jingjing Cai; Hua Zhong; Jinze Wu; Rui-Fang Chen; Huan Yang; Yousef Al-Abed; Ying Li; Xiaohui Li; Weihong Jiang; Marcelo Freitas Montenegro; Hong Yuan; Timothy Billiar; Alex F Chen
Journal:  Mol Med       Date:  2016-03-20       Impact factor: 6.354

3.  Bacterial infections in Myd88-deficient mice.

Authors:  Jason S Villano; Fang Rong; Timothy K Cooper
Journal:  Comp Med       Date:  2014-04       Impact factor: 0.982

Review 4.  Interplay between inflammation, immune system and neuronal pathways: effect on gastrointestinal motility.

Authors:  Benedicte-Y De Winter; Joris-G De Man
Journal:  World J Gastroenterol       Date:  2010-11-28       Impact factor: 5.742

5.  Role of interleukin-6 in hemopoietic and non-hemopoietic synergy mediating TLR4-triggered late murine ileus and endotoxic shock.

Authors:  B M Buchholz; R S Chanthaphavong; T R Billiar; A J Bauer
Journal:  Neurogastroenterol Motil       Date:  2012-04-10       Impact factor: 3.598

6.  Enrichment of Newly Synthesized Proteins following treatment of C2C12 Myotubes with Endotoxin and Interferon-γ.

Authors:  Catherine S Coleman; Bruce A Stanley; Charles H Lang
Journal:  Inflammation       Date:  2022-01-14       Impact factor: 4.657

7.  Signaling of high mobility group box 1 (HMGB1) through toll-like receptor 4 in macrophages requires CD14.

Authors:  Sodam Kim; Sun Young Kim; John P Pribis; Michael Lotze; Kevin P Mollen; Richard Shapiro; Patricia Loughran; Melanie J Scott; Timothy R Billiar
Journal:  Mol Med       Date:  2013-05-20       Impact factor: 6.354

Review 8.  Spontaneous and transgenic rodent models of inflammatory bowel disease.

Authors:  Susan Prattis; Abdo Jurjus
Journal:  Lab Anim Res       Date:  2015-06-26

9.  Innate immune responses induced by lipopolysaccharide and lipoteichoic acid in primary goat mammary epithelial cells.

Authors:  Omar Bulgari; Xianwen Dong; Alfred L Roca; Anna M Caroli; Juan J Loor
Journal:  J Anim Sci Biotechnol       Date:  2017-04-01

10.  Host-Microbiota Interaction is MyD88-Independent in the Intestinal Tract under Physiologic Condition.

Authors:  Shirin Moossavi; Nima Rezaei
Journal:  Avicenna J Med Biotechnol       Date:  2012-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.